Lebanon, New Hampshire 03766

  • Insomnia


The purpose of this study is to determine if CBT-I (cognitive behavioral therapy for insomnia) is a feasible treatment for insomnia in individuals undergoing cancer treatment.

Study summary:

This research study is a single arm feasibility trial in which all eligible participants receive five weekly sessions of CBT-I (cognitive behavioral therapy for insomnia) delivered before or during their cancer treatments. CBT-I is a non-drug behavioral treatment for insomnia and is considered the most effective treatment for insomnia. However, CBT-I is not routinely offered to cancer patients due to unknowns about its feasibility in this population. Data will be obtained at pre- and post-CBT-I and at eight-week follow-up, and will focus on acceptability, implementation, and efficacy in order to assess feasibility. The study will focus on cancer patients who are diagnosed with gastro-intestinal (GI) cancer.


Inclusion Criteria: 1. 18+ years of age 2. have insomnia disorder (SOL or WASO greater than 30 minutes for more than 6 nights in two weeks + daytime impairments) 3. are diagnosed with gastro-intestinal cancer; 4. have life expectancy > 6 months; 5. are fully ambulatory indicated by the provider-rated score of greater than 2 on the Eastern Cooperative Oncology Group (ECOG) performance measure; 6. will complete cancer treatments in no less than seven weeks, allowing for two weeks of assessments and five weeks of CBT-I; 7. are English-speaking and able to provide voluntary, written consent. Exclusion Criteria: 1. unmanaged sleep apnea indicated by the scores on the STOP-BANG Questionnaire suggesting high risk for sleep apnea and not receiving any sleep apnea treatment; 2. other sleep disorders; 3. bipolar disorder; 4. unmanaged serious mental illnesses; 5. suicidal ideation/intent/plan; 6. unstabilized pharmacological treatment for insomnia; 7. night-shift employment.



Primary Contact:

Principal Investigator
Wai S Chan, PhD
Dartmouth-Hitchcock Medical Center

Backup Contact:


Location Contact:

Lebanon, New Hampshire 03766
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 20, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.